Andrew J. Armanino, Director at Better Therapeutics, Inc. (BTTX), bought 17,000 shares at $6.96 ($118K) on 2021-11-29, disclosed to the SEC on 2021-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BTTX | BUY | 2023-04-12 | $503K | — | Filing → |
| BTTX | BUY | 2022-06-16 | $21K | — | Filing → |
| BTTX | BUY | 2022-06-10 | $41K | — | Filing → |